Tiagabine: the safety landscape

Epilepsia
I E Leppik

Abstract

Tiagabine (TGB) hydrochloride is a potential new antiepileptic drug (AED) undergoing clinical development. Experience in humans amounts to 1,810 patient-years of exposure. TGB was found to be tolerated in an integrated safety analysis of five double-blind, add-on therapy trials involving approximately 1,000 patients with epilepsy with difficult-to-control seizures with existing AEDs. Discontinuation resulting from adverse events were infrequent, occurring in 15% of patients receiving TGB compared to 5% receiving placebo. The most frequently reported adverse event was dizziness, which was usually transient and did not require medical intervention. Adverse events that were statistically significantly more common with TGB than placebo were dizziness, asthenia, nervousness, tremor, diarrhea, and depression (not major depression). Adverse events were usually mild to moderate in severity and transient, and most were associated with dose titration. The incidence, type, and severity of adverse events in long-term studies were comparable with those in short-term studies. Serious adverse events were uncommon and no idiosyncratic events were reported.

References

Jan 1, 1994·Epilepsia·H Mengel
Jan 1, 1995·Epilepsia·E Ben-Menachem
Jan 1, 1995·Epilepsia·M J Brodie

❮ Previous
Next ❯

Citations

Dec 4, 2003·Epilepsy Research·P Ryvlin, P Kahane
Jan 17, 2004·Epilepsy & Behavior : E&B·Rianne ReijsMarc De Krom
Nov 1, 1996·Epilepsy Research·R KälviäinenP J Riekkinen
Sep 12, 2003·Seizure : the Journal of the British Epilepsy Association·Kenneth Opeskin, Samuel F Berkovic
Jun 7, 2003·Epilepsy & Behavior : E&B·V de BorchgraveK van Rijckevorsel
Mar 1, 2003·Epilepsy & Behavior : E&B·Laura S. BoylanTerence A. Ketter
Aug 25, 2001·Epilepsia·P GentonE Perucca
May 27, 2010·Journal of Paediatrics and Child Health·Sascha MeyerLudwig Gortner
Jan 1, 1996·Epilepsia·B F Bourgeois
Sep 22, 2005·Epilepsy Currents·Siddhartha Nadkarni, Orrin Devinsky
Nov 24, 1998·Journal of Clinical Pharmacology·M S ThomsenT Kruse
Jun 15, 1999·Drug Metabolism and Drug Interactions·A RichensP C Pedersen
Mar 20, 2002·Pharmacotherapy·Thomas E Lackner
Feb 5, 1998·Lancet·J P Leach, M J Brodie
Mar 6, 2009·Nature Clinical Practice. Neurology·Andres M Kanner
Aug 17, 2004·Epilepsy Currents·Michael R. Sperling
Mar 1, 2000·Drug Metabolism and Drug Interactions·H KastbergK Wesnes
Oct 12, 2000·Revista de neurologia·C Garaizar
Oct 26, 1999·Epilepsia·S C Schachter
Nov 29, 2015·Neurologic Clinics·Sai Krishna J Munjampalli, Debra E Davis
Jul 12, 2005·Epilepsy Research·José F Téllez-ZentenoSamuel Wiebe
May 5, 2001·Expert Opinion on Pharmacotherapy·S C Schachter
Oct 20, 1998·Journal of the American Geriatrics Society·J I Sirven
Sep 14, 2000·Seizure : the Journal of the British Epilepsy Association·T FakhouryB Abou-Khalil
Oct 8, 1999·Seizure : the Journal of the British Epilepsy Association·J F Annegers, S P Coan
Sep 16, 1999·Seizure : the Journal of the British Epilepsy Association·S KnakeF Rosenow
Oct 25, 2012·Epilepsy & Behavior : E&B·Piero Perucca, Marco Mula
Aug 25, 2004·Seizure : the Journal of the British Epilepsy Association·Paul McKee
Jun 22, 2016·Expert Review of Neurotherapeutics·Kaiyan Tao, Xuefeng Wang
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Akshya VasudevAllan H Young
Nov 16, 2006·Epilepsia·Bettina Schmitz
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Marco MulaFrancesco Monaco
Nov 21, 2007·Emergency Medicine Australasia : EMA·Richard A ForbesFrank F S Daly
Dec 28, 1999·Epilepsia·M V Lambert, M M Robertson
Feb 7, 2014·The Cochrane Database of Systematic Reviews·Jennifer PulmanAnthony G Marson
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Akshya VasudevAllan H Young
Apr 16, 2019·Frontiers in Molecular Neuroscience·Nathanael O'Neill, Sergiy Sylantyev
Oct 15, 2019·The Cochrane Database of Systematic Reviews·Rebecca BresnahanAnthony G Marson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.